Patent 7935146 was granted and assigned to Edwards Lifesciences on May, 2011 by the United States Patent and Trademark Office.
A minimally invasive method of performing mitral annuloplasty is disclosed. An implantable device is positioned within the coronary sinus and tightened around the mitral annulus. Mitral valve regurgitation is monitored before, during, and/or after the tightening step. An on-going drug therapy may be determined, taking into account post-implantation hemodynamic function.